Tuesday, October 21, 2014 1:13:07 PM
Publish or perish. And if you can't find anything good to publish, it severely hurts your credibility. They would not be continuing with this Lympro study if the number of patients studied to date made a difference.
Finally, using any evaluation method, Lympro Ad v healthy controls has never been in the 90s sen and spec, so I am not holding my breath on better results.
JN is certainly free to report that the company expects better results, but that is not offering a sentient opinion. Do the same thing and expecting better results is not a healthy way to proceed.
The truth is incontrovertible. Malice may attack it, ignorance may deride it, but in the end, there it is.
Winston Churchill
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM